Search Results 261-270 of 17017 for pharmacogenetics
“Genetics and genomics are evolving rapidly and reshaping significant areas of the healthcare landscape and medical education,” says Joseph McInerney, executive ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Research. Mayo Clinic researchers have a rich history in advancing precision medicine for breast cancer. Projects include: Finding new therapies for breast ...
Learn about how our experts use testing, genetic counseling and treatments to help people with a family history of heart disease at risk of heart attacks.
About this study. The purpose of this study is to compare the effects of 5g of TU-100 three times per day (TU-100 is a botanical agent that modulates ...
The purpose of this study is to use Whole Exome Sequencing (WES) to identify genetic variants in patients and families who have received care for VACTERL ...
View Mayo Clinic education programs for aspiring researchers.
Use of photoaffinity labeling and mutagenesis to explore the molecular basis of natural cholecystokinin (CCK) ligand binding to its receptor. Refine the ...
View funding sources for the Epigenetic Etiology of Human Disease Lab led by Keith Robertson, Ph.D., at Mayo Clinic's campus in Minnesota.
The purpose of this study is to develop an RNA-seq based peripheral blood assay predictive of inflammation/rejection on allograft biopsy in adult heart ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.